1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Hip Reconstruction Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Hip Reconstruction Market, North America
3.1 Hip Reconstruction Market, North America, Revenue ($m), 2018-2033
3.2 Hip Reconstruction Market, North America, Revenue ($m), 2018-2033
3.3 Hip Reconstruction Market, North America, Volume (Units), 2018-2033
3.4 Hip Reconstruction Market, North America, Volume (Units), 2018-2033
3.5 Hip Reconstruction Market, North America, Company Share by Revenue ($m), 2025
4 Hip Reconstruction Market, Canada
4.1 Hip Reconstruction Market, Canada, Revenue ($m), 2018-2033
4.1.1 Partial Hip Replacement Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 Primary Hip Replacement Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Hip Reconstruction Market, Canada, Volume (Units), 2018-2033
4.2.1 Partial Hip Replacement Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 Primary Hip Replacement Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Hip Reconstruction Market, Canada, Average Price ($), 2018-2033
4.4 Hip Reconstruction Market, Canada, Company Share by Revenue ($m), 2025
5 Hip Reconstruction Market, Mexico
5.1 Hip Reconstruction Market, Mexico, Revenue ($m), 2018-2033
5.1.1 Partial Hip Replacement Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.2 Primary Hip Replacement Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Hip Reconstruction Market, Mexico, Volume (Units), 2018-2033
5.2.1 Partial Hip Replacement Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.2 Primary Hip Replacement Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Hip Reconstruction Market, Mexico, Average Price ($), 2018-2033
5.4 Hip Reconstruction Market, Mexico, Company Share by Revenue ($m), 2025
6 Hip Reconstruction Market, United States
6.1 Hip Reconstruction Market, United States, Revenue ($m), 2018-2033
6.1.1 Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.2 Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Hip Reconstruction Market, United States, Volume (Units), 2018-2033
6.2.1 Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2018-2033
6.2.2 Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Hip Reconstruction Market, United States, Average Price ($), 2018-2033
6.4 Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2025
7 Overview of Key Companies in North America Hip Reconstruction Market
7.1 Stryker Corp
7.1.1 Company Overview
7.2 Zimmer Biomet Holdings Inc
7.2.1 Company Overview
7.3 DePuy Synthes Inc
7.3.1 Company Overview
7.4 Smith & Nephew Plc
7.4.1 Company Overview
7.5 Enovis Corp
7.5.1 Company Overview
7.6 Exactech Inc
7.6.1 Company Overview
7.7 Corin Group Ltd
7.7.1 Company Overview
7.8 United Orthopedic Corp
7.8.1 Company Overview
8 Hip Reconstruction Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Dec 16, 2025: Ortho Development Appoints Brice Bedke as Vice President of Marketing
9.1.2 Nov 21, 2025: Stroke Prevention Study CREST-2 Stenting
9.1.3 Nov 05, 2025: Genesys Strike Negotiations Update
9.1.4 Nov 04, 2025: $1M Grant from Maryland Stem Cell Research Fund Supports Adipose Tissue Allograft Therapy for Osteoarthritis
9.1.5 Oct 30, 2025: Orthopedic Surgeon Expands Joint Care Options In Palm Coast
9.1.6 Oct 24, 2025: AI Tool Effectively Prepares Patients for Joint Replacement Surgery
9.1.7 Oct 06, 2025: Hendrick Health’s Joint Venture Program: What To Expect With Knee Or Hip Replacement Surgery
9.1.8 Aug 19, 2025: Zekjing Pharmaceuticals' Trispecific Antibody ZGGS34 Receives FDA Approval for Clinical Trial Application
9.1.9 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
9.1.10 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
9.1.11 May 20, 2025: FDA clears Trax Surgical’s compression staple system for orthopaedic use
9.1.12 Mar 12, 2025: Summit Orthopedics Receives Shoulder Arthroplasty (Shoulder Joint Replacement) Certification by the Joint Commission, Becoming the First Asc in Minnesota and the US to Achieve the Recognition
9.2 Financial Announcements
9.2.1 Apr 16, 2025: Assure Tech (Hangzhou) Receives CLIA Approval for FaStep Multi-Drug Urine Test Panel
9.2.2 Apr 15, 2025: Orthofix to Report First Quarter 2025 Financial Results
9.3 Government and Public Interest
9.3.1 Nov 18, 2025: Vesalio Receives Two FDA 510(k) Clearances, Advancing Its Comprehensive Thrombectomy Platform with Aspiration Technology
9.3.2 Sep 23, 2025: Early Alert: Automated Impella Controller Purge Retainer Fixation Issue from Abiomed
9.3.3 Mar 25, 2025: Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference
9.3.4 Mar 03, 2025: Orthofix to Participate in the 37th Annual Roth Conference
9.4 Legal And Regulatory
9.4.1 Jul 03, 2025: Innocan Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, Providing a Good Translational Model
9.4.2 Jun 13, 2025: FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer, Backed by Dana-Farber Research
9.4.3 Jun 04, 2025: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
9.5 Other Significant Developments
9.5.1 Nov 18, 2025: CurvaFix Expands National Market Access With Premier Inc. for General Orthopedic Trauma Products
9.5.2 Nov 04, 2025: $1M Grant from Maryland Stem Cell Research Fund Supports Adipose Tissue Allograft Therapy for Osteoarthritis
9.5.3 Oct 06, 2025: Hendrick Health’s Joint Venture Program: What To Expect With Knee Or Hip Replacement Surgery
9.5.4 Oct 02, 2025: USOP Chooses Johnson & Johnson as Official Vendor for Total Joint Products
9.5.5 Sep 15, 2025: Exactech Receives Court Confirmation of Restructuring Plan and Approval of Sale to Investor Group
9.5.6 Aug 30, 2025: Blood-Pressure Reductions With Baxdrostat in Patients With Uncontrolled or Resistant Hypertension
9.6 Product News
9.6.1 Nov 18, 2025: CurvaFix Expands National Market Access With Premier Inc. for General Orthopedic Trauma Products
9.6.2 Nov 04, 2025: $1M Grant from Maryland Stem Cell Research Fund Supports Adipose Tissue Allograft Therapy for Osteoarthritis
9.6.3 Nov 03, 2025: EmeTerm Wristband Reduces Postoperative Nausea and Vomiting in Orthopedic Surgeries
9.6.4 Oct 28, 2025: Zimmer Biomet Receives FDA Breakthrough Designation for Iodine-Treated Total Hip Replacement System
9.6.5 Oct 24, 2025: AI Tool Effectively Prepares Patients for Joint Replacement Surgery
9.6.6 Oct 21, 2025: Zimmer Biomet Showcases Robotics and Musculoskeletal Innovations at AAHKS Annual Meeting
9.6.7 Sep 25, 2025: Zimmer Biomet Receives Japan PMDA Approval for Iodine-Treated Total Hip Replacement System
9.7 Strategy And Business Planning
9.7.1 Nov 18, 2025: CurvaFix Expands National Market Access With Premier Inc. for General Orthopedic Trauma Products
9.7.2 Oct 30, 2025: Orthopedic Surgeon Expands Joint Care Options In Palm Coast
9.7.3 Oct 02, 2025: USOP Chooses Johnson & Johnson as Official Vendor for Total Joint Products
9.7.4 Sep 15, 2025: Exactech Receives Court Confirmation of Restructuring Plan and Approval of Sale to Investor Group
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer